ACADIA Pharmaceuticals (NASDAQ:ACAD) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.07 by 157.14 percent. This is a 12.5 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $307.959 million which beat the analyst consensus estimate of $295.857 million by 4.09 percent. This is a 16.40 percent increase over sales of $264.566 million the same period last year.